<!DOCTYPE html>
<html>
<head>
    <title>PressReader - The Straits Times: 2020-09-13 - As&#xAD;traZeneca re&#xAD;sumes vaccine trial af&#xAD;ter UK nod</title>
    <meta name="description" content="">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20200913/281668257390861" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>As&#xAD;traZeneca re&#xAD;sumes vaccine trial af&#xAD;ter UK nod</h1>
    <h2></h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20200913/textview" title="The Straits Times - 2020-09-13"><time>2020-09-13</time></a>
        - <span>TOP OF THE NEWS</span>
        - <span role="byline"></span>
    </section>

    <p>•</p>
    <p>LONDON Phar­ma­ceu­ti­cal gi­ant As­traZeneca has re­sumed a Covid-19 vaccine trial af­ter get­ting the all-clear from Bri­tish reg­u­la­tors, fol­low­ing a pause caused by a Bri­tish vol­un­teer fall­ing ill.</p>
    <p>“Clin­i­cal tri­als for the As­traZeneca Ox­ford coro­n­avirus vaccine, AZD1222, have re­sumed in the UK fol­low­ing con­fir­ma­tion by the Medicines Health Reg­u­la­tory Author­ity (MHRA) that it was safe to do so,” the com­pany said in a state­ment yes­ter­day.</p>
    <p>As­traZeneca an­nounced last</p>
    <p>Wednesday that it had “vol­un­tar­ily paused” its trial of the vaccine de­vel­oped along­side Ox­ford Univer­sity af­ter the vol­un­teer de­vel­oped an un­ex­plained ill­ness.</p>
    <p>An in­de­pen­dent com­mit­tee was drafted in to re­view safety, in what the com­pany and t he World Health Or­gan­i­sa­tion de­scribed as a rou­tine step.</p>
    <p>The com­mit­tee “has con­cluded its in­ves­ti­ga­tions and rec­om­mended to the MHRA that tri­als in the UK are safe to re­sume”, As­traZeneca said.</p>
    <p>The com­pany’s vaccine can­di­date is one of nine around the world cur­rently in late-stage phase 3 hu­man tri­als.</p>
    <p>In the United States, As­traZeneca be­gan en­rolling 30,000 vol­un­teers across dozens of sites on Aug 31, and the in­oc­u­la­tion is be­ing tested on smaller groups in Brazil and else­where in South Amer­ica.</p>
    <p>The AZD1222 vaccine uses a weak­ened ver­sion of a com­mon cold-caus­ing ade­n­ovirus en­gi­neered to code for the spike pro­tein that the Covid-19 coro­n­avirus uses to in­vade cells.</p>
    <p>Af­ter vac­ci­na­tion, this pro­tein is pro­duced in­side the hu­man body, which primes the im­mune sys­tem to at­tack the coro­n­avirus if the per­son is later in­fected.</p>


</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
